Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000862659 | SCV001003194 | benign | Long QT syndrome | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001536583 | SCV001753362 | likely benign | not provided | 2021-07-28 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26582918) |
Genome- |
RCV002253619 | SCV002524841 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336760 | SCV002638016 | likely benign | Cardiovascular phenotype | 2018-12-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001536583 | SCV004164284 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | AKAP9: BP4, BP7 |
Prevention |
RCV003938226 | SCV004756423 | likely benign | AKAP9-related disorder | 2019-06-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |